Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

AVCO

Avalon GloboCare (AVCO)

Avalon GloboCare Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVCO
DataHoraFonteTítuloCódigoCompanhia
29/06/202317:32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AVCOAvalon GloboCare Corporation
29/06/202307:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AVCOAvalon GloboCare Corporation
26/05/202318:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVCOAvalon GloboCare Corporation
26/05/202308:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AVCOAvalon GloboCare Corporation
22/05/202317:16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVCOAvalon GloboCare Corporation
16/05/202309:58Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:AVCOAvalon GloboCare Corporation
30/03/202317:37Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AVCOAvalon GloboCare Corporation
23/03/202307:04Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:AVCOAvalon GloboCare Corporation
09/03/202313:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVCOAvalon GloboCare Corporation
12/12/202212:41Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVCOAvalon GloboCare Corporation
21/11/202218:32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AVCOAvalon GloboCare Corporation
14/11/202218:51Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)NASDAQ:AVCOAvalon GloboCare Corporation
09/11/202218:00GlobeNewswire Inc.Avalon GloboCare Announces NASDAQ Ticker Symbol Change from “AVCO” to “ALBT”NASDAQ:AVCOAvalon GloboCare Corporation
08/11/202211:10GlobeNewswire Inc.Avalon GloboCare Signs Definitive Agreement for Transformational Acquisition of Leading Laboratory with 2021 Unaudited Revenue in Excess of $25 MillionNASDAQ:AVCOAvalon GloboCare Corporation
29/09/202210:00GlobeNewswire Inc.Avalon GloboCare Receives Allowance for Joint U.S. PatentNASDAQ:AVCOAvalon GloboCare Corporation
08/08/202210:00GlobeNewswire Inc.Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical SocietyNASDAQ:AVCOAvalon GloboCare Corporation
28/07/202207:09BenzingaWhy Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving PremarketNASDAQ:AVCOAvalon GloboCare Corporation
25/05/202210:00GlobeNewswire Inc.Avalon GloboCare to Present at the Jefferies 2022 Healthcare ConferenceNASDAQ:AVCOAvalon GloboCare Corporation
18/05/202210:00GlobeNewswire Inc.Avalon GloboCare Signs MOU to Form Strategic Partnership with Lu Daopei Hematology Institute to Develop Precision Companion Diagnostics for Cellular TherapyNASDAQ:AVCOAvalon GloboCare Corporation
27/04/202210:00GlobeNewswire Inc.Avalon GloboCare Expands IP Portfolio; Files 16 New Patent ApplicationsNASDAQ:AVCOAvalon GloboCare Corporation
14/02/202211:00GlobeNewswire Inc.Avalon GloboCare Expands its Cellular Immuno-Oncology Platform with the Addition of Novel Chimeric Antigen Receptor-Natural Killer (CAR-NK) Cell TherapiesNASDAQ:AVCOAvalon GloboCare Corporation
04/01/202211:00GlobeNewswire Inc.Avalon GloboCare Provides Year-End Business Update of Selective Scientific and Clinical ProgramsNASDAQ:AVCOAvalon GloboCare Corporation
22/12/202111:00GlobeNewswire Inc.Avalon GloboCare’s Chairman Converts Debt into Common Stock at 45% Premium to MarketNASDAQ:AVCOAvalon GloboCare Corporation
09/12/202111:00GlobeNewswire Inc.Avalon GloboCare Advances AI-Enhanced Protein Design Technology for Cellular Therapy DevelopmentNASDAQ:AVCOAvalon GloboCare Corporation
07/12/202111:04Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:AVCOAvalon GloboCare Corporation
14/10/202110:20GlobeNewswire Inc.Avalon GloboCare Jointly Files US and International Patent Application for Breakthrough S-Layer Coated Emulsome Technology (SLET) for Next-Generation Drug Delivery and Cellular ImmunotherapyNASDAQ:AVCOAvalon GloboCare Corporation
07/10/202110:00GlobeNewswire Inc.Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Co-develop Innovative In-Silico Technology, Enabling the Design and Synthesis of Novel Cell Membrane Receptor Targets for Cancer and Immune-Related DiseasesNASDAQ:AVCOAvalon GloboCare Corporation
23/09/202110:00GlobeNewswire Inc.Avalon GloboCare to Present at the Benzinga Healthcare Small Cap Conference on September 30thNASDAQ:AVCOAvalon GloboCare Corporation
13/09/202110:30GlobeNewswire Inc.Sysorex Elects Nasdaq-Listed Company CEO William Stilley to Board of DirectorsNASDAQ:AVCOAvalon GloboCare Corporation
04/08/202110:00GlobeNewswire Inc.UPMC and Pitt Develop New Cancer Immunotherapy with Avalon GloboCareNASDAQ:AVCOAvalon GloboCare Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:AVCO